Prestige^® 5 with Havlogen^®

Prestige® 5 with Havlogen® protects horses against 5 infectious diseases with a single, convenient vaccine. Prestige® 5 with Havlogen® is for use as an aid in the prevention of disease caused by Equine Encephalomyelitis (Eastern and Western), Equine Influenza (A2), Equine Rhinopneumonitis (EHV-1 and EHV-4), and Tetanus Toxoid. This killed vaccine contains the proprietary adjuvant Havlogen® which is designed to increase the efficacy of protection. Prestige® 5 with Havlogen® is safe for use in healthy horses at least 6 months of age. Foals nursing immune dams should be vaccinated when maternal antibody levels will allow active immunization. No reconstitution necessary. Needles and syringes sold separately.

Ingredients: Prestige® 5 with Havlogen® contains Eastern and Western Encephalomyelitis (sleeping sickness), Rhinopneumonitis respiratory (EHV-1 and EHV-4), Equine influenza (A2) KY 93, KY02, Newmarket 2/93 (cross-protects against: KY91, 93, 99, 02, OH03, Suffolk 89, NM 1/93 and 2/93 and South Africa 03), tetanus toxoid (KV), Florida 13 (FL13) and Richmond 07 (Clade 2). Neomycin, polymyxin B, nystatin and thimerosal added as preservatives.

Indications: Prestige® V with Havlogen® is for vaccination of healthy horses against Eastern and Western Encephalomyelitis, Equine Influenza Virus and Tetanus, and as an aid in the prevention of respiratory disease caused by Equine Herpesvirus.

Dosage and Administration: Administer 1 ml Prestige® V with Havlogen® Intramuscular and repeat the dose in 3 to 4 weeks. A 1 ml dose should be administered annually and at any time epidemic conditions exist or are reported and exposure is imminent.

Store at 2° to 7° C (35° to 45° F).

Caution: Consult a veterinarian before administering vaccines.

Shipping: Ships on ice overnight

Restrictions: Cannot ship to Canada or Puerto Rico; inquire regarding restrictions to other countries.